ArticleOncology letters2022

Cordycepin inhibits the proliferation and progression of NPC by targeting the MAPK/ERK and β-catenin pathways.

Yaqi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.